Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine for newly diagnosed primary CNS lymphoma. Schaff LR, Pentsova E, Malani R, Stone J, et al. Neuro Oncol 2026;28:1277-1285.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Schaff LR, Pentsova E, Malani R, Stone J, et al. Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine for newly diagnosed primary CNS lymphoma. Neuro Oncol 2026;28:1277-1285.
PMID: 41557853